Vitamin D has one clearly established job: preventing and reversing the bone-softening disease that a deficiency causes, rickets in children and osteomalacia in adults. The large trials of the last decade narrowed the rest of its reputation. In VITAL, 2000 IU a day in 25,871 adults who were already sufficient did not lower cancer, heart disease or fractures; a high daily dose did not stop prediabetes from becoming diabetes; and a single 500,000 IU annual dose increased falls.
The benefit is in correcting a shortfall, from sun, food, or a modest daily dose of about 1,000 to 2,000 IU. Pushing a blood level ever higher adds nothing, and past a point it causes harm.
Findings & Outcomes
What It Is
Vitamin D is a fat-soluble hormone. The body can make its own from sunlight, so it is not truly a vitamin. It comes in two forms: D3 (cholecalciferol), made in skin and found in animal foods, and D2 (ergocalciferol), from some plants and supplements. The body converts both to the same active hormone. A blood test measures neither form directly. It reports 25-hydroxyvitamin D, the circulating storage form, in nanograms per milliliter (ng/mL) or nanomoles per liter (nmol/L). The same status reads as about 30 ng/mL on one scale and about 75 nmol/L on the other, a small number and a large one for identical vitamin D.
Anatomy of the Practice
1Made in the skin
Ultraviolet B light converts a cholesterol precursor in your skin into vitamin D3. How much you make depends on skin tone, latitude, season and how much skin is exposed. This is the main natural source for most people; food supplies only a little.
2Activated in liver and kidney
Vitamin D from skin or food is converted first in the liver to 25-hydroxyvitamin D, the form a blood test measures, then in the kidney to its active hormone. That active form tells the gut to absorb calcium and helps lay it down in bone.
3Working on bone and muscle
With sufficient vitamin D, calcium is absorbed and bone mineralizes normally. Without it, bone softens and a proximal muscle weakness can set in. This is why the clearest benefits of supplementation appear in people who were deficient, and are absent in those who already had plenty.
How It Works
The mechanism is calcium. Vitamin D lets the gut absorb dietary calcium and lay it down in bone; without it, the skeleton loses mineral and softens. The reserve a blood test tracks, 25-hydroxyvitamin D, is what the body draws on when intake falls.
Vitamin D has a threshold. Below sufficiency, more helps a great deal; at sufficiency, more does nothing; sustained intake far above 4,000 IU a day causes harm.
What Changed
For a decade the message was simple: almost everyone is deficient, and a daily dose prevents cancer, heart disease, and fractures. It rested on observational studies, where people with low vitamin D were also the sicker ones. A low level marks poor health as much as it causes it. The housebound, the chronically ill, and people with obesity all tend to run low, and that confounds the correlation. The randomized trials of the 2010s tested the claim directly.
The trials that found nothing shared one feature: they enrolled people already sufficient in vitamin D. VITAL tested 2,000 IU a day against cancer and heart disease in 25,871 adults. D2d tested 4,000 IU a day against diabetes in adults with prediabetes. The VITAL fracture analysis and DO-HEALTH tested fractures and physical function in healthy adults over 70. All came back null, because there was no shortfall to correct.
The trials that found a benefit enrolled the deficient and the frail. Around 800 IU a day, usually paired with calcium, cuts fractures in older, often institutionalized people. Pooling 46 trials in over 75,000 people, vitamin D modestly cut acute respiratory infections, an odds ratio near 0.92. The reduction concentrated in the trials that dosed steadily each day.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Bone Density
Correcting a real deficiency reverses rickets in children and osteomalacia in adults
The clearest thing vitamin D does is prevent and cure the bone-softening disease that severe deficiency causes: rickets in children, osteomalacia in adults. If you are deficient, correcting it is worthwhile.
Vitamin D is required to absorb calcium and mineralize bone. Prolonged severe deficiency (25-hydroxyvitamin D roughly below 25 to 30 nmol/L, or about 10 to 12 ng/mL) impairs mineralization, producing rickets in growing children and osteomalacia in adults, with bone pain, muscle weakness and fractures. This is settled physiology and clinical medicine: repletion with vitamin D heals the defect. Holick's 2024 review of vitamin D and bone health summarizes the mechanism and the clinical picture. The benefit is specific to correcting deficiency, not to adding vitamin D on top of an already sufficient level.
Who this may not transfer to:Seen in children and adults of both sexes; the deficiency physiology is the same across sexes.
The study · 1
Holick 2024, Adv Food Nutr Res · Adv Food Nutr Res
No fewer fractures on 2000 IU a day in 25,871 already-replete adults
In healthy adults who were already sufficient in vitamin D, taking 2000 IU a day did not reduce fractures of any kind. Supplementing a sufficient person does not protect their bones.
LeBoff 2022 (N Engl J Med), an ancillary study of the VITAL cohort, analyzed incident fractures in 25,871 adults not selected for vitamin D deficiency, low bone mass or osteoporosis. Vitamin D3 2000 IU/day did not reduce total fractures (HR 0.98, 95% CI 0.89 to 1.08), nonvertebral fractures (0.97) or hip fractures (1.01) over a median 5.3 years. This sits alongside the deficiency and institutionalized-benefit findings: correcting a deficiency helps bone, adding vitamin D to a replete person does not.
Who this may not transfer to:Men 50 and older and women 55 and older; no fracture benefit in either sex when replete.
The study · 1
LeBoff 2022, N Engl J Med (VITAL fractures) · N Engl J Med
About 800 IU a day cut hip fractures roughly 30% in older adults
Vitamin D lowers fracture risk in the people most likely to be deficient: the frail elderly, especially in care homes, and usually alongside calcium. The benefit shows up only at an adequate daily dose, around 800 IU.
Bischoff-Ferrari's 2012 pooled analysis of 11 double-blind RCTs (31,022 participants, mostly older women) found antifracture benefit only in the highest quartile of actual intake (median 800 IU/day, range 792 to 2,000): hip fracture reduced 30% (HR 0.70) and nonvertebral fracture 14% (HR 0.86), with no benefit at lower intakes. The classic Chapuy 1992 trial (3,270 institutionalized women, mean age 84) gave 800 IU D3 plus 1,200 mg calcium daily and cut hip fractures 43% and nonvertebral fractures 32% over 18 months. The population that benefits is older, frailer and often deficient, and calcium is usually part of the regimen.
Who this may not transfer to:Trials were mostly older women; the benefit at an adequate intake is expected in older men who are similarly deficient, though most data are in women.
The studies · 2
Bischoff-Ferrari 2012, N Engl J Med · N Engl J Med
Chapuy 1992, N Engl J Med · N Engl J Med
Cancer Risk And Outcome
No fewer cancers on 2000 IU a day in 25,871 adults (VITAL)
Taking 2000 IU of vitamin D a day did not lower the chance of getting cancer in a large trial of adults who were not selected for deficiency. The idea that routine vitamin D prevents cancer did not hold up.
VITAL (Manson 2019, N Engl J Med) randomized 25,871 US adults (men 50+, women 55+, not selected for low vitamin D) to 2000 IU/day vitamin D3 or placebo. Over a median 5.3 years there was no significant reduction in the primary endpoint of invasive cancer (HR 0.96, 95% CI 0.88 to 1.06). A secondary signal for lower cancer mortality emerged in later analyzes, but the primary prevention result was null. Most participants were vitamin D sufficient at baseline (mean about 31 ng/mL).
Who this may not transfer to:Men 50 and older and women 55 and older; the null held across both sexes.
The study · 1
Manson 2019, N Engl J Med (VITAL) · N Engl J Med
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Heart And Vascular
No fewer heart attacks or strokes on 2000 IU a day in 25,871 adults (VITAL)
Vitamin D at 2000 IU a day did not lower heart attacks, strokes or cardiovascular death in the same large trial. Routine supplementation did not protect the heart.
In VITAL (Manson 2019, N Engl J Med), the co-primary endpoint of major cardiovascular events (heart attack, stroke, cardiovascular death) was not reduced by 2000 IU/day vitamin D3 versus placebo: HR 0.97 (95% CI 0.85 to 1.12) over a median 5.3 years in 25,871 adults. Individual components were also null. As with the cancer endpoint, participants were largely vitamin D sufficient at entry, so this speaks to supplementing a replete population.
Who this may not transfer to:Men 50 and older and women 55 and older; the null held across both sexes.
The study · 1
Manson 2019, N Engl J Med (VITAL) · N Engl J Med
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Blood Sugar
No fewer type 2 diabetes cases on 4000 IU a day in 2,423 people with prediabetes
Even at a high 4000 IU a day, vitamin D did not meaningfully stop people with prediabetes from developing type 2 diabetes.
The D2d trial (Pittas 2019, N Engl J Med) randomized 2,423 adults with prediabetes to 4000 IU/day vitamin D3 or placebo. Over a median 2.5 years, the hazard ratio for new-onset diabetes was 0.88 (95% CI 0.75 to 1.04), which did not reach significance. Most participants were vitamin D sufficient at baseline (median about 28 ng/mL); a later subgroup analysis suggested possible benefit in those who were deficient, consistent with the recurring theme that repletion, not routine supplementation, is where any effect is.
Who this may not transfer to:Adults of both sexes with prediabetes; the null was consistent across sexes.
The study · 1
Pittas 2019, N Engl J Med (D2d) · N Engl J Med
Longevity And Mortality
No gains in blood pressure, fractures, strength, infections or memory on 2000 IU a day in adults 70+ (DO-HEALTH)
In generally healthy people over 70, a daily 2000 IU of vitamin D did not improve blood pressure, fractures, leg strength, infections or memory.
DO-HEALTH (Bischoff-Ferrari 2020, JAMA) randomized 2,157 community-dwelling adults aged 70 and older across five European countries, in a 2x2x2 design testing 2000 IU/day vitamin D3, 1 g/day omega-3, and a home strength-exercise program. Vitamin D showed no benefit on any of the six primary endpoints: systolic and diastolic blood pressure, nonvertebral fractures, physical performance, infection rate, and cognition. The participants were relatively healthy and mostly sufficient at baseline, again the population in whom supplementation does the least.
Who this may not transfer to:European adults 70 and older of both sexes; the null applied across sexes.
The study · 1
Balance And Falls
700 to 1000 IU a day cut falls about 19% in older people who were low to begin with
At an adequate daily dose, vitamin D reduced falls in older people who were deficient. In healthy, already-sufficient community-dwelling adults the benefit is not clear, and higher bolus doses can make falls worse.
Bischoff-Ferrari's 2009 meta-analysis (8 RCTs, 2,426 participants) found supplemental vitamin D at 700 to 1000 IU/day reduced falls by 19% (pooled RR 0.81), with no effect at lower doses or lower achieved 25-OHD levels, and the signal strongest where baseline vitamin D was low. The picture has since become mixed: the 2018 US Preventive Services Task Force review of community-dwelling adults found no benefit from supplementation for preventing falls and recommended against vitamin D for that purpose, and its companion review recommended against low-dose vitamin D plus calcium for the primary prevention of fractures. So the reading is a benefit concentrated in deficient or institutionalized people, not a general fall-prevention tool.
Who this may not transfer to:Older adults of both sexes; the benefit tracks baseline deficiency, not sex.
The studies · 3
Bischoff-Ferrari 2009, BMJ · BMJ
US Preventive Services Task Force (Grossman) 2018, JAMA (falls) · JAMA 2018;319(16):1696-1704
US Preventive Services Task Force (Grossman) 2018, JAMA (fractures) · JAMA 2018;319(15):1592-1599
A single 500,000 IU annual dose increased falls and fractures in older women (RR 1.15 and 1.26)
Giving older women one huge yearly dose of vitamin D (500,000 IU) increased their falls and fractures, not preventing them, with most of the extra falls in the months right after the dose. Big infrequent doses are not a shortcut.
Sanders 2010 (JAMA) randomized 2,256 community-dwelling women aged 70+ at high fracture risk to a single annual oral dose of 500,000 IU vitamin D3 or placebo for three to five years. The vitamin D group had more falls (incidence rate ratio 1.15, 95% CI 1.02 to 1.30) and more fractures (RR 1.26, 95% CI 1.00 to 1.59), with the excess concentrated in the first three months after each dose. The likely explanation is the sharp spike in blood vitamin D from a bolus. This is a clear signal that more is not better and that megadose bolus dosing can cause harm.
Who this may not transfer to:Tested only in older women; the bolus-dose harm has not been separately quantified in men.
The study · 1
Sanders 2010, JAMA · JAMA
High monthly doses (60,000 IU) led to more falls than 24,000 IU, about 67% versus 48%
Older adults who had already fallen and were given high monthly vitamin D doses to push their blood level up fell more often than those on a moderate dose. Pushing the blood level higher with big monthly doses did not prevent falls; it went with more of them.
Bischoff-Ferrari 2016 (JAMA Internal Medicine) randomized 200 adults aged 70+ with a prior fall to 24,000 IU/month vitamin D3, 60,000 IU/month, or 24,000 IU plus calcifediol, for one year. The two higher-dose groups had more falls (66.9% and 66.1%) than the 24,000 IU group (47.9%), and reaching the highest 25-OHD levels (44.7 to 98.5 nmol/L) was associated with more falls. Higher doses achieved higher blood levels but worse fall outcomes, reinforcing that pushing vitamin D above sufficiency offers no gain and may cause harm.
Who this may not transfer to:Adults 70 and older of both sexes with a prior fall; the high-dose harm is not specific to one sex.
The study · 1
Bischoff-Ferrari 2016, JAMA Intern Med · JAMA Intern Med
Muscle And Strength
A small muscle-strength gain (SMD 0.17), mostly in deficient or older adults
Correcting a vitamin D deficiency gives a small boost in muscle strength, mostly in older people and those who were clearly low to start with. In people who are already sufficient, it does not add strength.
Beaudart 2014 (J Clin Endocrinol Metab) pooled 30 RCTs and found vitamin D supplementation had a small significant positive effect on global muscle strength (standardized mean difference 0.17, 95% CI 0.02 to 0.31), with no significant effect on muscle mass or power. The strength effect was larger and clearest in participants with baseline 25-OHD below 30 nmol/L and in those aged over 65. Severe deficiency can cause a proximal myopathy (weakness in the hips and shoulders) that improves with repletion, which fits the pattern that the benefit is in correcting a deficiency.
Who this may not transfer to:Pooled across adults of both sexes; the strength effect tracks deficiency and age, not sex.
The study · 1
Beaudart 2014, J Clin Endocrinol Metab · J Clin Endocrinol Metab
Respiratory Infection
No fewer respiratory infections or covid-19 when 6,200 UK adults were tested and treated
A large recent trial that tested people and gave vitamin D to those who were low found it did not cut respiratory infections or covid-19. The earlier small benefit did not carry over.
CORONAVIT (Jolliffe 2022, BMJ) used a test-and-treat design in 6,200 UK adults: those with 25-OHD below 75 nmol/L were offered 800 or 3,200 IU/day for six months. Correcting vitamin D status did not reduce all-cause acute respiratory infection (the higher-dose arm hazard ratio was close to 1) or covid-19 versus no offer. This tempers the earlier meta-analytic signal and is why respiratory protection is presented as small and unsettled, not established.
Who this may not transfer to:UK adults of both sexes; the null applied across sexes.
The study · 1
A small drop in respiratory infections across 46 trials (OR 0.92)
Vitamin D gives a small reduction in coughs, colds and chest infections, and the effect was larger in trials that used a steady daily dose.
Jolliffe 2021 (Lancet Diabetes & Endocrinology) pooled 46 RCTs with 75,541 participants and found vitamin D reduced the odds of at least one acute respiratory infection (OR 0.92, 95% CI 0.86 to 0.99). The protection was greater with daily dosing (OR about 0.78) than with large intermittent bolus doses, and the analysis found no significant effect in any baseline 25-OHD subgroup. The overall effect is small, and later large trials using a test-and-treat approach have not consistently reproduced it.
Who this may not transfer to:Pooled across all ages and both sexes; the odds ratio was consistent across sexes.
The study · 1
Jolliffe 2021, Lancet Diabetes Endocrinol · Lancet Diabetes Endocrinol
Immune Function
About 22% fewer new autoimmune diseases on 2000 IU a day over five years (VITAL)
Taking 2000 IU of vitamin D a day for about five years lowered the rate of new autoimmune disease by roughly a fifth in a large trial of older adults. The effect showed up with or without fish oil, and because autoimmune disease is uncommon the number of cases actually prevented was small.
The VITAL autoimmune-disease ancillary (Hahn 2022) followed 25,871 US adults, men aged 50 and older and women 55 and older, randomized to 2000 IU/day vitamin D3, 1 g/day marine omega-3, both, or placebo. Over a median 5.3 years, confirmed autoimmune disease was lower in the vitamin D arm (HR 0.78, 95% CI 0.61 to 0.99, P=0.05), a 22% relative reduction, spanning conditions such as rheumatoid arthritis, polymyalgia rheumatica, autoimmune thyroid disease and psoriasis. Omega-3 alone did not significantly reduce confirmed cases, and the vitamin D and omega-3 effects were independent. Most participants were vitamin-D-sufficient at baseline, and because autoimmune disease is uncommon the absolute number of cases prevented across five years was small.
Who this may not transfer to:Roughly balanced men and women, all older adults (men 50 and older, women 55 and older). The result has not been shown in younger people, and baseline vitamin D status shapes who is likely to benefit, so the size of any effect in a younger or more deficient population is not established here.
The study · 1
Hahn 2022, BMJ (VITAL autoimmune disease ancillary) · BMJ 2022;376:e066452
How to Get Enough
Ways to Do It
Most people need no plan beyond sunlight and food. Get some sun with skin exposed, eat the foods that carry vitamin D, and if you are likely to be deficient, add a modest daily dose. Testing is for people with a specific reason to check.
Short, regular time outdoors with some skin exposed lets your body make its own vitamin D. Dark skin, high latitude, or little time outside all mean you make less. If you live somewhere with few daylight hours through winter, sun alone will not cover those months.
Food supplies only modest amounts, but it adds up. Fatty fish such as salmon, sardines, and mackerel are the richest natural source; egg yolks and cod liver oil carry some. In many countries milk, some plant milks, and breakfast cereals are fortified. Building a couple of servings of oily fish into the week is a reasonable food-first move.
For an adult likely to be deficient, generic vitamin D3 (cholecalciferol) at around 1,000 to 2,000 IU a day is a sensible amount. Take a small amount every day; steady daily dosing is what the beneficial trials used. Staying at or below the 4,000 IU a day upper limit covers the great majority of people.
Routine testing for everyone is not necessary and is easy to over-do. A 25-hydroxyvitamin D level is worth checking only with a specific reason. Common ones: very limited sun, darker skin at a high latitude, or a malabsorption condition like celiac or inflammatory bowel disease. Also osteoporosis or a prior fragility fracture, being older and housebound, or certain long-term medications. In those cases a test shows whether you are actually low, the group that benefits from correction.
Go Deeper
- Resistance training: builds the bone and muscle that vitamin D helps mineralize, and the main lever in the frail.
- Protein and muscle: the dietary partner to resistance training for holding on to muscle with age.
- Balance and falls: what actually reduces falls in older people, where vitamin D helps only the deficient and can harm at high bolus doses.
- Omega-3 fish oil: the other supplement tested in the same large trials, with its own gap between reputation and result.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Sustained doses above 4,000 IU a day can raise blood calcium to toxic levels
Vitamin D toxicity results from sustained intake well above the tolerable upper limit (4,000 IU/day for adults), typically driving 25-hydroxyvitamin D above about 150 ng/mL (375 nmol/L). The mechanism is hypercalcemia: nausea, vomiting, muscle weakness, confusion, excessive urination and thirst, kidney stones and acute kidney injury, described in a 2024 clinical review of acute vitamin D toxicity and in case reports of older adults over-supplementing. Toxicity is essentially always from high-dose supplements or dosing errors, never from sun or food. The distance between a sensible replacement dose (up to about 1,000 to 2,000 IU/day for most adults) and a toxic one is large, which is why routine megadosing is unnecessary for most people.Aberger 2024, Int J Mol SciYu 2024, Medicine (Baltimore)
Large bolus doses increase falls
The harm in the research is specific to very large, infrequent doses. A single 500,000 IU annual dose increased falls and fractures in older women, and high monthly doses aimed at raising blood levels caused more falls than a moderate dose. If you supplement, take a modest daily amount; a large occasional dose carries the downside without the benefit.
Some people should only supplement with medical guidance
People with conditions that already raise blood calcium, such as sarcoidosis or primary hyperparathyroidism, should supplement only under medical guidance. Extra vitamin D can push their blood calcium higher still.
Toxicity comes only from sustained high doses
Toxicity occurs only with sustained intake well past the 4,000 IU a day ceiling, not with a dose that corrects a deficiency. The gap between a sensible dose and a harmful one is wide. It comes from high-dose supplements, not from sun or food.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Should everyone take vitamin D?
The large trials of routine supplementation in already-sufficient people came back null, so a blanket habit for everyone is not supported. Correcting a genuine deficiency is a different matter and is worthwhile, since it reverses the bone-softening disease a severe shortage causes. The people who gain are those actually low: many older, frail, housebound, or malabsorbing people, and those who get little sun. A 25-hydroxyvitamin D reading is the only way to know whether you are one of them.
Does vitamin D prevent cancer or heart disease?
No, at least not in people who already have enough. VITAL tested exactly that and found nothing over about 5 years. It never enrolled deficient adults, the only group vitamin D is known to help.
How much should I take?
For an adult likely to be deficient, about 1,000 to 2,000 IU of D3 a day, taken every day rather than in one large occasional dose. Correcting a low level is the whole benefit; the trials found nothing beyond it.
Should I get my vitamin D level tested?
For most people, no. Routine testing is easy to over-order and rarely changes the plan. A 25-hydroxyvitamin D check is worth doing only when a specific reason applies, and a result already in the sufficient range needs no action.
Can you take too much?
Yes, but only from sustained megadosing. Sun and food never produce a toxic amount; that risk sits only with high-dose supplements.
Months of intake far above the 4,000 IU ceiling can push blood calcium to harmful levels, a state called hypercalcemia, bringing nausea, weakness, confusion, and kidney trouble.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 19 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.